The page is the record's research on the issuer — no analyst, no rating, no view.

# Sumitomo Pharma Co.,Ltd. (Prime Market: 4506) — research page

As of 2026-11-06 · jp-cm-kg · record version 1

## Identity and listing

The issuer is Sumitomo Pharma Co.,Ltd., listed on the Prime Market under ticker 4506. Its ISIN is JP3495000006 and its LEI is 529900D60UKVYLJ2OJ79. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.

## The disclosure read

The record holds 11 filings in the twelve months to 2026-11-06, across 8 filing days. Of these, 4 are ad hoc, 5 are regulatory filings and 2 are results. The median gap between filing days is 14 days. The latest filing is dated 2026-11-02, is a regulatory filing, and is 4 days before the record date. The Prime Market median cadence gap is 29.0 days, with a median of 10 filings and a median latency of 70.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days, with a median of 8.0 filings and a median latency of 85.0 days.

## Auditor

The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. The auditor changes are not on the record.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The halt flag is listed, not halted.

## Orderability

For Qualified Institutional Investors, the signal is null and the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

## Coverage

The record names 7 research houses on the issuer's investor-relations page: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; Daiwa Securities Co. Ltd.; Jefferies (Japan) Limited; JPMorgan Securities Japan Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; and SMBC Nikko Securities Inc.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.

## Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4506 (the disclosure lines)
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YH3M (the auditor)
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.sumitomo-pharma.com/ir/shareholder/coverage.html (coverage)
- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4506 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4506 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
